MEMBRANOUS GLOMERULONEPHRITIS

Clinical trials for MEMBRANOUS GLOMERULONEPHRITIS explained in plain language.

Never miss a new study

Get alerted when new MEMBRANOUS GLOMERULONEPHRITIS trials appear

Sign up with your email to follow new studies for MEMBRANOUS GLOMERULONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug duo aims to halt silent kidney damage

Disease control Recruiting now

This study is testing whether combining two existing drugs, rituximab and cyclosporine, is safe and more effective for treating membranous nephropathy, an autoimmune disease that damages the kidneys' filters. The goal is to reduce harmful protein loss in urine and achieve lasting…

Matched conditions: MEMBRANOUS GLOMERULONEPHRITIS

Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

MEMBRANOUS GLOMERULONEPHRITIS

Get alerted when new MEMBRANOUS GLOMERULONEPHRITIS trials appear

New drug duo aims to halt silent kidney damage